Literature DB >> 8136618

Bacillary angiomatosis in a German patient with AIDS.

T Schneider1, R Ullrich, A Schmitt-Gräff, C Bergs, L Reiterer, T Dissmann, M Zeitz, E O Riecken.   

Abstract

A 52-year old male homosexual patient with acquired immunodeficiency syndrome (AIDS) presented in our clinic with multiple nodular papules (more than 100) spread over the whole body which had developed within 3 months. Bacillary angiomatosis was suspected, which is a bacterial infectious disease recognized recently mainly in patients with AIDS. Histological and immunohistochemical examinations of extirpated skin lesions were in agreement with the diagnosis, and the detection of rod-shaped bacteria in the lesions by Warthin-Starry silver stain confirmed it. The patient was treated with 2 x 100 mg doxycycline per day. The fever disappeared, and the cutaneous lesions showed a slight tendency to improve. However, after 5 days of therapy the patient showed increasing weakness, with muscle and bone pain. The patient died 10 days after the doxycycline therapy had been started. The cutaneous lesions in bacillary angiomatosis may resemble Kaposi's sarcoma and may therefore be misdiagnosed. The disease may be fatal, but timely antibiotic treatment is usually effective; therefore, the diagnosis of bacillary angiomatosis is important. Although many cases have been reported from the United States, only one case is known from Europe. Our finding of bacillary angiomatosis in a German AIDS patient supports the concept of a worldwide distribution of this bacterial agent.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8136618     DOI: 10.1007/bf00231117

Source DB:  PubMed          Journal:  Clin Investig        ISSN: 0941-0198


  24 in total

1.  Clinical and pathological features of bacillary peliosis hepatis in association with human immunodeficiency virus infection.

Authors:  L A Perkocha; S M Geaghan; T S Yen; S L Nishimura; S P Chan; R Garcia-Kennedy; G Honda; A C Stoloff; H Z Klein; R L Goldman
Journal:  N Engl J Med       Date:  1990-12-06       Impact factor: 91.245

2.  Intracerebral bacillary angiomatosis in HIV.

Authors:  P J Harris
Journal:  Ann Intern Med       Date:  1992-11-01       Impact factor: 25.391

3.  [LATE RECURRENCES OF VOLHYNIA FEVER].

Authors:  W MOHR; F WEYER
Journal:  Dtsch Med Wochenschr       Date:  1964-02-07       Impact factor: 0.628

4.  Intracerebral bacillary angiomatosis in a patient infected with human immunodeficiency virus.

Authors:  D H Spach; L A Panther; D R Thorning; J E Dunn; J J Plorde; R A Miller
Journal:  Ann Intern Med       Date:  1992-05-01       Impact factor: 25.391

Review 5.  The clinical spectrum of bacillary angiomatosis.

Authors:  G F Webster; C J Cockerell; A E Friedman-Kien
Journal:  Br J Dermatol       Date:  1992-06       Impact factor: 9.302

6.  Unique vascular skin lesions associated with human immunodeficiency virus.

Authors:  E H Knobler; D N Silvers; K C Fine; J H Lefkowitch; M E Grossman
Journal:  JAMA       Date:  1988 Jul 22-29       Impact factor: 56.272

7.  Histiocytoid hemangioma with features of angiolymphoid hyperplasia and Kaposi's sarcoma. A study by light microscopy, electron microscopy, and immunologic techniques.

Authors:  E Waldo; G S Sidhu; R Stahl; S Zolla-Pazner
Journal:  Am J Dermatopathol       Date:  1983-12       Impact factor: 1.533

8.  Rochalimaea henselae sp. nov., a cause of septicemia, bacillary angiomatosis, and parenchymal bacillary peliosis.

Authors:  D F Welch; D A Pickett; L N Slater; A G Steigerwalt; D J Brenner
Journal:  J Clin Microbiol       Date:  1992-02       Impact factor: 5.948

9.  An atypical subcutaneous infection associated with acquired immune deficiency syndrome.

Authors:  M H Stoler; T A Bonfiglio; R T Steigbigel; M Pereira
Journal:  Am J Clin Pathol       Date:  1983-11       Impact factor: 2.493

10.  Isolation of Rochalimaea species from cutaneous and osseous lesions of bacillary angiomatosis.

Authors:  J E Koehler; F D Quinn; T G Berger; P E LeBoit; J W Tappero
Journal:  N Engl J Med       Date:  1992-12-03       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.